Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Cancer Research|May 20, 2018
Combined VEGF and PD-L1 Blockade Displays Synergistic Treatment Effects in an Autochthonous Mouse Model of Small Cell Lung CancerLydia Meder, Philipp Schuldt, Martin Thelen, et al.
Blood|February 9, 2026
MRD-2 in the GHSG HD21 trial assessed by a validated circulating tumor DNA sequencing assayJan-Michel Heger, Julia Mattlener, Helen Kaul, et al.
RMD Open|March 4, 2025
Major adverse cardiovascular, thromboembolic and malignancy events in the filgotinib rheumatoid arthritis and ulcerative colitis clinical development programmesXavier Mariette, Sven Borchmann, Sandrine Aspeslagh, et al.
JCI Insight|May 22, 2024
Blocking the angiopoietin-2-dependent integrin β-1 signaling axis abrogates small cell lung cancer invasion and metastasisLydia Meder, Charlotte Isabelle Orschel, Christoph Julius Otto, et al.
Blood|February 17, 2019
Active surveillance for nodular lymphocyte-predominant Hodgkin lymphomaSven Borchmann, Erel Joffe, Craig H Moskowitz, et al.
Blood|November 10, 2023
Entirely noninvasive outcome prediction in central nervous system lymphomas using circulating tumor DNAJan-Michel Heger, Julia Mattlener, Jessica Schneider, et al.
Blood|October 28, 2020
Tumor and microenvironment response but no cytotoxic T-cell activation in classic Hodgkin lymphoma treated with anti-PD1Sarah Reinke, Paul J Bröckelmann, Ingram Iaccarino, et al.
Cell Reports|April 30, 2020
Inhibition of Tumor VEGFR2 Induces Serine 897 EphA2-Dependent Tumor Cell Invasion and Metastasis in NSCLCCaroline Volz, Sara Breid, Carolin Selenz, et al.
Med (New York, N.Y.)|May 19, 2022
In-depth cell-free DNA sequencing reveals genomic landscape of Hodgkin's lymphoma and facilitates ultrasensitive residual disease detectionSophia Sobesky, Laman Mammadova, Melita Cirillo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 30, 2024
Circulating Tumor DNA Sequencing for Biologic Classification and Individualized Risk Stratification in Patients With Hodgkin LymphomaJan-Michel Heger, Laman Mammadova, Julia Mattlener, et al.
Pageof 5